Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM

Diabetologia- Germany

doi 10.1007/s001250050613

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search